Caleres director granted 1,950 shares of stock

LANGENSTEIN MOLLY reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

LANGENSTEIN MOLLY reported acquisition or exercise transactions in this Form 4 filing.

Caleres Inc director Molly Langenstein received a grant of 1,950 shares of Common Stock on August 1, 2026, at $12.82 per share. The shares were granted in lieu of her quarterly cash payment for Board services, bringing her direct holdings to 37,256 shares.

Insider Trade Summary

Grant/Award: 1,950 shares

Grant/Award 1 txn

Insider LANGENSTEIN MOLLY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	1,950	$12.82	$25K

Holdings After Transaction: Common Stock — 37,256 shares (Direct)

Footnotes (1)

1. F1. Represents shares of stock granted in lieu of quarterly cash payment for services rendered as a member of the Company's Board of Directors.

Key Figures

Shares granted: 1,950 shares Grant price: $12.82 per share Shares owned after grant: 37,256 shares

3 metrics

Shares granted 1,950 shares Common Stock grant to director on August 1, 2026

Grant price $12.82 per share Transaction price per share for the stock award

Shares owned after grant 37,256 shares Director’s direct Common Stock holdings following the transaction

Key Terms

Grant, award, or other acquisition, in lieu of quarterly cash payment, Board of Directors

3 terms

Grant, award, or other acquisition regulatory

"Transaction code description is "Grant, award, or other acquisition""

in lieu of quarterly cash payment financial

"Represents shares of stock granted in lieu of quarterly cash payment"

Board of Directors regulatory

"services rendered as a member of the Company's Board of Directors"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Caleres (CAL) director Molly Langenstein report in this Form 4 filing?

Molly Langenstein reported a grant of 1,950 shares of Caleres Common Stock on August 1, 2026. The shares were awarded as compensation for serving on the Board, increasing her direct holdings to 37,256 shares after the transaction.

At what price were the 1,950 Caleres (CAL) shares granted to director Molly Langenstein?

The 1,950 Caleres shares were granted at $12.82 per share. This price is shown as the transaction price per share for the stock award, which was issued as part of her compensation for Board of Directors services.

How many Caleres (CAL) shares does Molly Langenstein own after this stock grant?

After the reported grant, Molly Langenstein directly owns 37,256 shares of Caleres Common Stock. This total reflects the addition of 1,950 shares granted in lieu of her regular quarterly cash compensation as a Board member.

Was the Caleres (CAL) stock grant to Molly Langenstein part of her Board compensation?

Yes. The filing states the 1,950-share grant represents stock granted in lieu of the quarterly cash payment for services rendered as a member of Caleres’ Board of Directors, making it a form of equity compensation.

Did Molly Langenstein buy Caleres (CAL) shares on the open market in this Form 4?

No. The transaction is coded as a grant, award, or other acquisition, not an open-market purchase. The 1,950 shares were issued by Caleres as stock compensation in place of a cash retainer for Board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 02:01 PM Accepted by SEC EDGAR 08/03/2026 - 02:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LANGENSTEIN MOLLY

(Last) (First) (Middle)

8300 MARYLAND AVE.

(Street)

ST. LOUIS MISSOURI 63105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CALERES INC [ CAL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/01/2026		A		1,950(1)	A	$12.82	37,256	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of stock granted in lieu of quarterly cash payment for services rendered as a member of the Company's Board of Directors.

	Thomas C. Burke, Attny in Fact for Molly Langenstein	08/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)